Astera Labs (NASDAQ:ALAB) Given New $275.00 Price Target at Susquehanna

Astera Labs (NASDAQ:ALAB) had its target price hoisted by equities researchers at Susquehanna from $230.00 to $275.00 in a report released on Friday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Susquehanna’s price target points to a potential downside of 8.24% from the company’s previous close.

ALAB has been the topic of a number of other research reports. Rothschild & Co Redburn began coverage on shares of Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target on the stock. Morgan Stanley upped their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. UBS Group boosted their price target on Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a report on Monday, June 29th. Finally, JPMorgan Chase & Co. upped their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Thirteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $284.25.

Astera Labs Stock Performance

Shares of ALAB stock opened at $299.69 on Friday. The company has a market capitalization of $51.37 billion, a P/E ratio of 202.49, a PEG ratio of 2.89 and a beta of 3.66. Astera Labs has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The stock has a 50 day moving average price of $359.89 and a two-hundred day moving average price of $229.21.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter last year, the business earned $0.33 earnings per share. The business’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts predict that Astera Labs will post 1.86 earnings per share for the current year.

Insiders Place Their Bets

In other news, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the sale, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of Astera Labs stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $200.16, for a total value of $28,012,592.16. Following the sale, the chief executive officer directly owned 3,929,183 shares in the company, valued at approximately $786,465,269.28. The trade was a 3.44% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 1,676,845 shares of company stock worth $444,928,806. 10.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Atreides Management LP lifted its stake in shares of Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the period. Amundi grew its stake in Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after purchasing an additional 1,319,643 shares during the period. Artisan Partners Limited Partnership purchased a new stake in Astera Labs in the fourth quarter worth $148,980,000. Goldman Sachs Group Inc. raised its holdings in Astera Labs by 189.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after purchasing an additional 858,693 shares in the last quarter. Finally, State Street Corp raised its holdings in Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after purchasing an additional 760,358 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.